Anti-Müllerian Hormone in Female Adolescent Cancer Patients Before, During, and After Completion of Therapy: A Pilot Feasibility Study

Abstract Study Objective Alkylating agents are implicated in premature ovarian insufficiency. To optimize counseling regarding future ovarian function in survivors of adolescent cancer, we describe anti-Müllerian hormone (AMH) levels in female adolescents at diagnosis, during, and shortly after comp...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of pediatric & adolescent gynecology 2016-12, Vol.29 (6), p.599-603
Hauptverfasser:	Gupta, Abha A., MD, MSc, Lee Chong, Amy, MD, MSc, Deveault, Catherine, BSc, Traubici, Jeffrey, MD, Maloney, Anne Marie, MSM, NP-PAEDS, Knight, Samantha, MD, Lorenzo, Armando, MD, Allen, Lisa, MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Amenorrhea - chemically induced Anti-Mullerian Hormone - therapeutic use Anti-Müllerian hormone Antineoplastic Agents, Alkylating - adverse effects Cancer Chemotherapy Child Cyclophosphamide - adverse effects Feasibility Studies Female Fertility preservation Humans Neoplasms - drug therapy Obstetrics and Gynecology Pediatrics Pilot Projects Primary Ovarian Insufficiency - chemically induced Primary Ovarian Insufficiency - prevention & control Prospective Studies Survivors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!